by Gary Pepper M.D. | Oct 1, 2007 | diabetes
More on the Avandia Debate: Common Sense vs. the Statisticians I previously addressed the issue of “relative risk†in this blog, as it applies to the perceived hazard of using Avandia (rosiglitazone) to treat diabetics. To gain a better understanding of the true...
by Gary Pepper M.D. | Jun 7, 2007 | diabetes
Today’s NY Times carries a front page article about the dangers of Actos and Avandia, two popular diabetes medications. The reason behind the news story is that the FDA has finally required the two companies that make these diabetes drugs to carry a “black...
Loading ...